PPD

PPD
Name	Postpartum depression
Field	Psychiatry, Obstetrics
Symptoms	Low mood, anhedonia, anxiety, fatigue, irritability
Complications	Suicidality, impaired bonding, infant developmental delay
Onset	Within 4 weeks to 12 months after childbirth
Duration	Variable
Risks	Prior mood disorder, obstetric complications, social stressors
Differential	Baby blues, bipolar disorder, psychosis
Treatment	Psychological therapies, antidepressants, social support

PPD Postpartum depression is a mood disorder affecting individuals after childbirth characterized by persistent low mood, anxiety, and functional impairment. It intersects with obstetric care, perinatal psychiatry, and public health and has implications for maternal, infant, and family outcomes. Diagnosis and management draw on recommendations from major organizations and evidence from randomized trials and cohort studies.

Terminology and Abbreviations

Common abbreviations include DSM for diagnostic criteria in Diagnostic and Statistical Manual of Mental Disorders, ICD from International Classification of Diseases, CBT as used in programs from National Institute for Health and Care Excellence (NICE) and American College of Obstetricians and Gynecologists (ACOG), and EPDS which refers to the screening tool developed by Cox and Holden and used in studies by United Kingdom National Health Service. Other frequently cited organizations and instruments include WHO instruments, US Preventive Services Task Force (USPSTF) guidance, and literature from Royal College of Psychiatrists and American Psychiatric Association.

Epidemiology and Risk Factors

Epidemiological estimates vary across settings: cohort analyses from United States Centers for Disease Control and Prevention (CDC), population registers in Sweden and Denmark, and community surveys in India, Nigeria, and Brazil report prevalences ranging widely. Major risk factors identified in meta-analyses include a prior history noted in studies of Major depressive disorder cohorts, antenatal depression in trials cited by Cochrane Collaboration, socioeconomic adversity documented in work from World Bank and United Nations Children's Fund, intimate partner violence reported in publications from World Health Organization, and obstetric complications discussed in Lancet systematic reviews. Additional correlates appear in longitudinal studies from Harvard University, Johns Hopkins University, and multicenter trials coordinated by Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Pathophysiology and Causes

Multifactorial models synthesize hormonal, neurobiological, genetic, and psychosocial contributors. Endocrine hypotheses draw on postpartum changes in estrogen and progesterone reported in endocrine research from Endocrine Society journals and neurosteroid work linked to Allopregnanolone studies. Neuroinflammatory pathways are explored in research programs at National Institutes of Health (NIH) and laboratories affiliated with Massachusetts General Hospital and Karolinska Institutet. Genetic and epigenetic associations have been examined in genome-wide association studies from consortia including Psychiatric Genomics Consortium and cohort data from Avon Longitudinal Study of Parents and Children. Psychosocial models reference attachment literature from John Bowlby and stress models used in work by Hans Selye and contemporary investigations from University of Oxford and Yale University.

Clinical Presentation and Diagnosis

Presentation ranges from mild mood disturbance to severe depressive episodes; classic symptom clusters mirror criteria in editions of Diagnostic and Statistical Manual of Mental Disorders and coding in International Classification of Diseases. Screening commonly uses EPDS and PHQ instruments validated in trials from Cochrane Collaboration and field studies by World Health Organization. Differential diagnosis includes the transient condition described in literature from Royal College of Obstetricians and Gynaecologists, bipolar disorder characterized in texts from Stanley Medical Research Institute, and postpartum psychosis reported in case series from National Health Service trusts and academic centers like Cambridge University Hospitals.

Management and Treatment

Evidence-based management integrates psychological, pharmacological, and social interventions. Psychotherapies such as CBT and interpersonal psychotherapy (IPT) are supported by randomized trials conducted at University of California, San Francisco and Columbia University. Pharmacotherapy with selective serotonin reuptake inhibitors has been studied in multicenter trials reviewed by American Psychiatric Association guidelines; considerations for breastfeeding reference recommendations from Academy of Breastfeeding Medicine and lactation research at La Leche League-related literature. Novel agent trials, including neurosteroid modulators, appear in publications from Food and Drug Administration (FDA)-regulated studies and industry-sponsored trials reported in New England Journal of Medicine. Community-based interventions and home-visiting programs are evaluated in public health trials from Nurse-Family Partnership and Healthy Start initiatives.

Prognosis and Prevention

Prognosis depends on severity, access to care, and social supports; longitudinal follow-up studies from Duke University School of Medicine, University of Toronto, and national registries in Norway document variable recovery trajectories and risks for recurrence. Prevention strategies include antenatal screening recommended by American College of Obstetricians and Gynecologists and psychosocial interventions trialed by Cochrane Collaboration and World Health Organization programs. Policy approaches and maternal leave research feature in analyses by Organisation for Economic Co-operation and Development (OECD) and public health reports from Centers for Disease Control and Prevention.

Category:Mood disorders